89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer von Verhoeff, Sarah R, van de Donk, Pim P, Aarntzen, Erik HJG, Oosting, Sjoukje F, Brouwers, Adrienne H, Miedema, Iris HC, Voortman, Jens, van Oordt, Willemien C Menke-van der Houven, Boellaard, Ronald, Vriens, Dennis, Slingerland, Marije, Hermsen, Rick, van Engen-Grunsven, Ilse, Heskamp, Sandra, van Herpen, Carla ML

Volltext

PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients von Miedema, Iris H. C., Zwezerijnen, Gerben J. C., Huisman, Marc C., Doeleman, Ellen, Mathijssen, Ron H. J., Lammers, Twan, Hu, Qizhi, Dongen, Guus A. M. S., Rijcken, Cristianne J. F., Vugts, Danielle J., Menke‐van der Houven van Oordt, C. Willemien

Volltext

Clinical Validity of 16α-[ 18 F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer... von van Geel, Jasper J L, Boers, Jorianne, Elias, Sjoerd G, Glaudemans, Andor W J M, de Vries, Erik F J, Hospers, Geke A P, van Kruchten, Michel, Kuip, Evelien J M, Jager, Agnes, Menke-van der Houven van Oordt, Willemien C, van der Vegt, Bert, de Vries, Elisabeth G E, Schröder, Carolina P

Volltext

ESR Bridges: image-guided breast cancer treatment de-escalation-a multidisciplinary view von Mann, Ritse M, Rubio, Isabel T, Menke-van der Houven van Oordt, C Willemien, Fuchsjäger, Michael

Volltext

The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype von Kramer, Iris, Schaapveld, Michael, Oldenburg, Hester S A, Sonke, Gabe S, McCool, Danielle, van Leeuwen, Flora E, Van de Vijver, Koen K, Russell, Nicola S, Linn, Sabine C, Siesling, Sabine, Menke-van der Houven van Oordt, C Willemien, Schmidt, Marjanka K

Volltext

Response to Letter RE: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study von Debets, Pien, Dreijerink, Koen M.A., Engelsman, Anton, Dahele, Max, Haak, Harm R., Steenaard, Rebecca V., Kapiteijn, Ellen, Corssmit, Eleonora, Menke – van der Houven van Oordt, Willemien

Volltext

Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study von Debets, Pien, Dreijerink, Koen M A, Engelsman, Anton, Dahele, Max, Haak, Harm R, Steenaard, Rebecca V, Kapiteijn, Ellen, Corssmit, Eleonora, Menke-van der Houven van Oordt, C Willemien

Volltext

Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial von Boni, Valentina, Fidler, Mary J, Arkenau, Hendrik-Tobias, Spira, Alexander, Meric-Bernstam, Funda, Uboha, Nataliya, Sanborn, Rachel E, Sweis, Randy F, LoRusso, Patricia, Nagasaka, Misako, Garcia-Corbacho, Javier, Jalal, Shadia, Harding, James J, Kim, Stella K, Miedema, Iris H C, Vugts, Danielle J, Huisman, Marc C, Zwezerijnen, Gerben J C, van Dongen, Guus A M S, Menke van der Houven van Oordt, C Willemien, Wang, Song, Dang, Tam, Zein, Ivan A, Vasiljeva, Olga, Lyman, Susan K, Paton, Virginia, Hannah, Alison, Liu, Joyce F

Volltext

Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis? von van Prehn, Joffrey, Menke‐van der Houven van Oordt, C. Willemien, de Rooij, Madelon L., Meijer, Ellen, Bomers, Marije K., van Dijk, Karin

Volltext

Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles von Rijcken, Cristianne J.F., De Lorenzi, Federica, Biancacci, Ilaria, Hanssen, Rob G.J.M., Thewissen, Marielle, Hu, Qizhi, Atrafi, Florence, Liskamp, Rob M.J., Mathijssen, Ron H.J., Miedema, Iris H.C., Menke - van der Houven van Oordt, C. Willemien, van Dongen, Guus A.M.S., Vugts, Danielle J., Timmers, Matt, Hennink, Wim E., Lammers, Twan

Volltext

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors von Menke-van der Houven van Oordt, C Willemien, Gomez-Roca, Carlos, van Herpen, Carla, Coveler, Andrew L, Mahalingam, Devalingam, Verheul, Henk M W, van der Graaf, Winette T A, Christen, Randolph, Rüttinger, Dominik, Weigand, Stefan, Cannarile, Michael A, Heil, Florian, Brewster, Michael, Walz, Antje-Christine, Nayak, Tapan K, Guarin, Ernesto, Meresse, Valerie, Le Tourneau, Christophe

Volltext

[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma von Verhoeff, Sarah R, Oosting, Sjoukje F, Elias, Sjoerd G, van Es, Suzanne C, Gerritse, Sophie L, Angus, Lindsay, Heskamp, Sandra, Desar, Ingrid M E, Menke-van der Houven van Oordt, C Willemien, van der Veldt, Astrid A M, Arens, Anne I J, Brouwers, Adrienne H, Eisses, Bertha, Mulders, Peter F A, Hoekstra, Otto S, Zwezerijnen, Gerben J C, van der Graaf, Winette T A, Aarntzen, Erik H J G, Oyen, Wim J G, van Herpen, Carla M L

Volltext

Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocol von Civil, Yasmin A, Oei, Arlene L, Duvivier, Katya M, Bijker, Nina, Meijnen, Philip, Donkers, Lorraine, Verheijen, Sonja, van Kesteren, Zdenko, Palacios, Miguel A, Schijf, Laura J, Barbé, Ellis, Konings, Inge R H M, -van der Houven van Oordt, C Willemien Menke, Westhoff, Paulien G, Meijer, Hanneke J M, Diepenhorst, Gwen M P, Thijssen, Victor, Mouliere, Florent, Slotman, Berend J, van der Velde, Susanne, van den Bongard, H J G Desirée

Volltext

Current state and upcoming opportunities for immunoPET biomarkers in lung cancer von Slebe, Maarten, Pouw, Johanna E.E., Hashemi, Sayed M.S., Menke-van der Houven van Oordt, C. Willemien, Yaqub, Maqsood M., Bahce, Idris

Volltext

Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis von Goos, Jeroen A. C M, de Cuba, Erienne M V, Coupé, Veerle M H, Diosdado, Begoña, Delis-Van Diemen, Pien M, Karga, Cemile, Beliën, Jeroen A M, Oordt, C. Willemien Menke-Van der Houven van, Geldof, Albert A, Meijer, Gerrit A, Hoekstra, Otto S, Fijneman, Remond J A

Volltext

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions... von Jager, Agnes, de Vries, Elisabeth G. E., der Houven van Oordt, C. Willemien Menke-van, Neven, Patrick, Venema, Clasina M., Glaudemans, Andor W. J. M., Wang, Yamei, Bagley, Rebecca G., Conlan, Maureen G., Aftimos, Philippe

Volltext

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting von Bos, Manouk K, Verhoeff, Sarah R, Oosting, Sjoukje F, Menke-van der Houven van Oordt, Willemien C, Boers, Ruben G, Boers, Joachim B, Gribnau, Joost, Martens, John W M, Sleijfer, Stefan, van Herpen, Carla M L, Wilting, Saskia M

Volltext

89Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs von Miedema, Iris H. C., Wijngaarden, Jessica E., Pouw, Johanna E. E., Zwezerijnen, Gerben J. C., Sebus, Hylke J., Smit, Egbert, de Langen, Adrianus J., Bahce, Idris, Thiele, Andrea, Vugts, Daniëlle J., Boellaard, Ronald, Huisman, Marc C., Menke-van der Houven van Oordt, C. Willemien

Volltext

Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis von Werter, Inge M, Remmelzwaal, Sharon, Burchell, George L, de Gruijl, Tanja D, Konings, Inge R, van der Vliet, Hans J, Menke-van der Houven van Oordt, C Willemien

Volltext

Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET von Wijngaarden, Jessica E., Jauw, Yvonne W. S., Zwezerijnen, Gerben J. C., de Wit-van der Veen, Berlinda J., Vugts, Daniëlle J., Zijlstra, Josée M., van Dongen, Guus A. M. S., Boellaard, Ronald, Menke-van der Houven van Oordt, C. Willemien, Huisman, Marc C.

Volltext